Coastal Bridge Advisors LLC Invests $4.29 Million in Danaher Corporation $DHR

Coastal Bridge Advisors LLC acquired a new stake in shares of Danaher Corporation (NYSE:DHRFree Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 5,958 shares of the conglomerate’s stock, valued at approximately $4,290,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Main Street Group LTD bought a new stake in Danaher during the first quarter valued at about $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher in the second quarter worth about $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher during the 3rd quarter valued at about $25,000. WFA of San Diego LLC purchased a new position in shares of Danaher during the 2nd quarter valued at about $26,000. Finally, Hilton Head Capital Partners LLC bought a new position in shares of Danaher during the 4th quarter valued at approximately $27,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

NYSE:DHR opened at $215.74 on Friday. The stock has a 50-day moving average price of $198.69 and a 200 day moving average price of $192.35. The stock has a market capitalization of $151.67 billion, a P/E ratio of 38.32, a P/E/G ratio of 2.68 and a beta of 0.78. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the previous year, the firm earned $0.77 EPS. The firm’s revenue was up 5.5% compared to the same quarter last year. Equities research analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on DHR shares. HSBC reduced their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. DZ Bank initiated coverage on shares of Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target for the company. Guggenheim reduced their price objective on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Stifel Nicolaus decreased their price objective on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Finally, Evercore restated an “outperform” rating and set a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Read Our Latest Stock Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.